Literature DB >> 15057473

Oral streptococci exhibit diverse susceptibility to human beta-defensin-2: antimicrobial effects of hBD-2 on oral streptococci.

Eisaku Nishimura1, Akiko Eto, Masatoshi Kato, Shuichi Hashizume, Susumu Imai, Tosiki Nisizawa, Nobuhiro Hanada.   

Abstract

We examined the antimicrobial effects of human beta-defensin-2 (hBD-2) on 17 species of oral streptococci to investigate the involvement of antimicrobial peptide activity in oral microflora development and the clinical use of the antimicrobial peptide for oral microflora control. Oral streptococci exhibit diverse levels of susceptibility to human beta-defensin-2 (hBD-2). Two major cariogenic bacterial species, Streptococcus mutans ( S. mutans) and S. sobrinus, were found to be susceptible to the peptide, indicating that it is a potential therapeutic agent for preventing dental caries. S. mitis exhibited the lowest susceptibility to the peptide. S. mitis is a major indigenous bacterium in the oral microflora, and our results suggest that it might possess a certain resistance mechanism against hBD-2.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15057473     DOI: 10.1007/s00284-003-4108-3

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  14 in total

1.  Antibacterial Peptides: Opportunities for the Prevention and Treatment of Dental Caries.

Authors:  Adam Pepperney; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2011-06       Impact factor: 4.609

2.  Salivary antimicrobial peptide expression and dental caries experience in children.

Authors:  Renchuan Tao; Richard J Jurevic; Kimberly K Coulton; Marjorie T Tsutsui; Marilyn C Roberts; Janet R Kimball; Norma Wells; Jeffery Berndt; Beverly A Dale
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

3.  Mechanisms of decreased susceptibility to beta-defensins by Treponema denticola.

Authors:  Catherine A Brissette; Sheila A Lukehart
Journal:  Infect Immun       Date:  2007-02-26       Impact factor: 3.441

4.  Streptococcus mutans strains recovered from caries-active or caries-free individuals differ in sensitivity to host antimicrobial peptides.

Authors:  E Phattarataratip; B Olson; B Broffitt; F Qian; K A Brogden; D R Drake; S M Levy; J A Banas
Journal:  Mol Oral Microbiol       Date:  2011-01-31       Impact factor: 3.563

5.  Surface response of fluorine polymer-incorporated resin composites to cariogenic biofilm adherence.

Authors:  Mariko Gyo; Toru Nikaido; Koichi Okada; Junichi Yamauchi; Junji Tagami; Khairul Matin
Journal:  Appl Environ Microbiol       Date:  2008-01-11       Impact factor: 4.792

6.  A lactotransferrin single nucleotide polymorphism demonstrates biological activity that can reduce susceptibility to caries.

Authors:  Daniel H Fine; Gokce A Toruner; Kabilan Velliyagounder; Vandana Sampathkumar; Dipti Godboley; David Furgang
Journal:  Infect Immun       Date:  2013-03-04       Impact factor: 3.441

7.  Oral antimicrobial peptides and biological control of caries.

Authors:  Beverly A Dale; Renchuan Tao; Janet R Kimball; Richard J Jurevic
Journal:  BMC Oral Health       Date:  2006-06-15       Impact factor: 2.757

8.  The level of beta defensin-2 in saliva and its expression in parotid gland epithelial cells after probiotic (Lactobacillus reuteri) induction to inhibit Streptococcus mutans in caries.

Authors:  Tuti Kusumaningsih; M S Subijanto; Retno Indrawati; R Rini Devijanti
Journal:  Eur J Dent       Date:  2016 Oct-Dec

9.  Innate immune response to oral bacteria and the immune evasive characteristics of periodontal pathogens.

Authors:  Suk Ji; Youngnim Choi
Journal:  J Periodontal Implant Sci       Date:  2013-02-28       Impact factor: 2.614

10.  A study on β-defensin-2 and histatin-5 as a diagnostic marker of early childhood caries progression.

Authors:  Anna Jurczak; Dorota Kościelniak; Monika Papież; Palina Vyhouskaya; Wirginia Krzyściak
Journal:  Biol Res       Date:  2015-10-31       Impact factor: 5.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.